Entities / Company
Kardigan.
company in South San Francisco, United States
- Reports this week
- 0
- Active events
- 0
- Connections
- 7
What's happening
Gone quiet
No new reports in 90+ days-
Kardigan debuted on the Nasdaq stock exchange and is based in Princeton, New Jersey.Some support1 report
-
Kardigan licensed a lead drug from Bristol-Myers Squibb, utilizing technology further developed by Mayo Clinic, while studying ataciguat originating at Sanofi.Some support1 report
-
Kardigan plans to list its shares on the Nasdaq stock exchange.Some support1 report
-
Kardigan, a company based in New Jersey, is currently positioning itself for an Initial Public Offering (IPO) in the United States.Some support2 reports
No events began in the chosen period. Widen it, or reset.
Around Kardigan this week
News at the entities that move Kardigan most-
Mayo Clinic StructuralNovoheart, a subsidiary of Medera Inc., is collaborating with Mayo Clinic on mini-heart models, aligning with FDA guidelines for drug development.Moves Kardigan
-
Nasdaq StructuralPrivia Health Group, Inc. shares are listed on the Nasdaq exchange, and Citigroup reissued a buy rating on the stock.Moves Kardigan
-
Bristol-Myers Squibb TransactionalBristol-Myers Squibb and Özlem Türeci presented late-stage oncology pipeline data and joint development activity in Mainz.Moves Kardigan
-
South San Francisco Shared contextPliant Therapeutics announced its presentation at the European Society for Medical Oncology (ESMO) Congress on October 1, 2026.Moves Kardigan
-
New Jersey Shared contextAn incident occurred in Peters Township, New Jersey, which was reported by CNN and Associated Press.Moves Kardigan
Connections
The 6 strongest of 7, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Mayo Clinic Structural
Kardigan utilizes technology that was further developed by Mayo Clinic.
-
Nasdaq Structural
Kardigan is listed on the Nasdaq stock exchange.
-
Bristol-Myers Squibb Transactional
Kardigan licensed a lead drug from Bristol-Myers Squibb.
-
Sanofi Structural
Kardigan is involved in studying ataciguat, a compound that originated from Sanofi's research.
-
South San Francisco Shared context
Kardigan is headquartered in South San Francisco.
-
New Jersey Shared context
The company Kardigan operates within the geographical and legal context of New Jersey.
History
Events by the month they beganJune 2026
4 events- Kardigan debuted on the Nasdaq stock exchange and is based in Princeton, New Jersey.
- Kardigan licensed a lead drug from Bristol-Myers Squibb, utilizing technology further developed by Mayo Clinic, while studying ataciguat originating at Sanofi.
- Kardigan plans to list its shares on the Nasdaq stock exchange.
- Kardigan, a company based in New Jersey, is currently positioning itself for an Initial Public Offering (IPO) in the United States.